Cardiovascular disease risks in chemotherapy-treated testicular cancer patients
PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA Genetic variation is promoting the risk of cardiovascular disease (CVD) in chemotherapy-treated testicular cancer (TC) patients due to alterations of SNPs (Single Nucleotide Polymorphism) from normal sequences. TC patients treated with platinum-based chemotherapy (PBC) when genotyped, were analyzed with 141 independent genomic loci, containing 324 SNPs contributing to CVD occurrence. […]